Nymox Pharmaceutical Corp (NYMX): James George Robinson , director of Nymox Pharmaceutical Corp purchased 17,500 shares on Jun 27, 2016. The Insider buying transaction was reported by the company on Jul 1, 2016 to the Securities and Exchange Commission. The shares were purchased at $3.50 per share for a total value of $61,690.00 , the company said in a SEC Form 4 Filing.
Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 24, 2016, James George Robinson (director) purchased 22,500 shares at $2.97 per share price.
Shares of Nymox Pharmaceutical Corporation (NYMX) ended Wednesday, Jun 29, 2016 session in red amid volatile trading. The shares closed down -0.22 points or -5.90% at $3.51 with 4,19,925 shares getting traded. Post opening the session at $3.8, the shares hit an intraday low of $3.41 and an intraday high of $3.8 and the price vacillated in this range throughout the day. The company has a market cap of $157 M and the number of outstanding shares has been calculated to be 4,47,88,419 shares. The 52-week high of Nymox Pharmaceutical Corporation is $4.37 and the 52-week low is $1.13.